Pacific Restates Loss

Pacific Biometrics restated its third-quarter loss to $1.3 million, or 88 cents a share, from the loss of $1.1 million, or 62 cents, that the Irvine company reported May 11.

Pacific, which develops diagnostic tests and laboratory services for chronic diseases, also amended its loss for the nine-months ended March 31 to $1.30 a share, from a loss of $1.04 a share reported earlier.

The wider loss is due to a noncash adjustment of $187,400 for accelerated depreciation of the company’s December acquisition of rights to a diagnostic skin patch technique.